ISPOR Releases Final Program, Speakers for ISPOR Europe 2018

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2P06HV3 on October 31, 2018 at 04:12PM The International Society for Pharmacoeconomics and Outcomes Research this week announced the final program and speakers for its Nov. 10-14 ISPOR Europe 2018 meeting in Barcelona, Spain. According to a press release, the conference in Europe pulls some 5,000 stakeholders in […]

Pfizer CEO: Business as Normal Come January

from tHEORetically Speaking: The HealthEconomics.Com Blog at https://www.healtheconomics.com/government/pfizer-ceo-business-as-normal-come-january on October 31, 2018 at 03:42PM Pfizer CEO Ian Read says the company will return to “business as normal” and continue with scheduled price increases at the start of 2019, despite pressure from President Donald Trump, FirstWord Pharma reports. The company in July deferred price hikes after […]

“We are fierce, independent thinkers and intelligent”: Social capital and stigma management among mothers who refuse vaccines

from Social Science & Medicine at https://www.sciencedirect.com/science/article/pii/S0277953618306233?dgcid=rss_sd_all on October 31, 2018 at 03:39PM Publication date: Available online 30 October 2018 Source: Social Science & Medicine Author(s): Jennifer A. Reich Abstract Despite measurable benefits of childhood vaccines, mothers with high levels of social privilege are increasingly refusing some or all vaccines for their children. These mothers […]

The effect of school sports facilities on physical activity, health and socioeconomic status in adulthood

from Social Science & Medicine at https://www.sciencedirect.com/science/article/pii/S027795361830621X?dgcid=rss_sd_all on October 31, 2018 at 03:39PM Publication date: Available online 30 October 2018 Source: Social Science & Medicine Author(s): Nicole Black, David Johnston, Carol Propper, Michael Shields Abstract This paper focuses on the long-term impacts of attending a high school with inadequate sports facilities. We use prospective data […]

New Study Finds Immigrants Pay More in Private Insurance Premiums Than They Receive In Benefits

from AcademyHealth Blog at http://bit.ly/2OhEGDs on October 31, 2018 at 01:19PM New Study Finds Immigrants Pay More in Private Insurance Premiums Than They Receive In Benefits Published in the October edition of Health Affairs, findings from our study using nationally representative data show that immigrants heavily subsidize private insurance of US-born enrollees and boost profits […]

Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review

from The European Journal of Health Economics at http://bit.ly/2PAupXq on October 31, 2018 at 07:33AM Abstract Background Bone metastases are highly prevalent in breast, prostate, lung and colon cancers. Their symptoms negatively affect quality of life and functionality and optimal management can mitigate these problems. There are two different targeted agents to treat them: bisphosphonates […]

HEDS presentation on Screening for severe combined immunodeficiency: Using probabilistic uncertainty analysis of economic models to assess the reliability of screening policy decisions

from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2qi8ING on October 31, 2018 at 07:00AM Professor Jim Chilcott delivered a presentation at the ISNS conference in Bratislava earlier this month. His presentation was titled: Screening for severe combined immunodeficiency: Using probabilistic uncertainty analysis of economic models to assess the reliability of screening policy decisions. The […]

90% of health plans think the use of alternative payment models will increase in the coming years

from Healthcare Economist at http://bit.ly/2AEjJyZ on October 31, 2018 at 06:31AM A recent report from the Health Care Payment Learning and Action Network (HCP LAN) examines how providers are getting paid in the U.S. today.  Traditionally, health care providers (e.g., physicians, hospitals) were paid via fee-for-service (FFS).  Fee-for-service means that every time a provider does […]

FirstWord Report Looks at Pharma Perspective on RWD

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2qkP4ka on October 30, 2018 at 05:22PM A FirstWord report from March 2017 delves into the pharma perspective on real-world data, and includes interviews with seven senior decision-markers involved in RWD and real-world evidence. The report, “Real World Data Capabilities: Benchmarking Pharma Companies,” offers an overview of RWD, […]

Parental warmth and flourishing in mid-life

from Social Science & Medicine at http://bit.ly/2ESmsZx on October 30, 2018 at 01:18PM Publication date: Available online 30 October 2018 Source: Social Science & Medicine Author(s): Ying Chen, Laura D. Kubzansky, Tyler J. VanderWeele Abstract Objective This study examined the longitudinal association between parental warmth and offspring flourishing in mid-life. We also considered associations between […]

Evaluating Cost Savings Associated with Los Angeles County’s Mental Health Full Service Partnerships

from RAND Research Topic: Health and Health Care at http://bit.ly/2CRTd6N on October 30, 2018 at 12:18PM This report estimates government spending and cost savings associated with outcomes targeted by Full Service Partnership programs in Los Angeles County: homelessness, criminal justice detention, health care (inpatient and outpatient), and employment.

Including intangible costs into the cost-of-illness approach: a method refinement illustrated based on the PM 2.5 economic burden in China

from The European Journal of Health Economics at http://bit.ly/2qiWJPP on October 30, 2018 at 08:30AM Abstract The concentrations of particulate matter with aerodynamic diameters less than 2.5 µm (PM2.5) and 10 µm (PM10) is a widespread concern and has been demonstrated for 103 countries. During the past few years, the exposure–response function (ERf) has been widely used […]

ISPOR Europe 2018 Conference to Focus on Improving Healthcare Systems in Europe

from ISPOR News & Press Releases at http://bit.ly/2qjPK9k on October 30, 2018 at 07:36AM More Than 5000 Healthcare Stakeholders Will Convene on 10-14 November 2018 in Barcelona, Spain Lawrenceville, NJ, USA—October 30, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), released the final program and speakers for its upcoming ISPOR Europe 2018 […]

Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

from PharmacoEconomics at http://bit.ly/2Q6L426 on October 30, 2018 at 06:42AM Abstract Objective We estimated the cost consequence of Italian National Health System (NHS) investment in direct-acting antiviral (DAA) therapy according to hepatitis C virus (HCV) treatment access policies in Italy. Methods A multistate, 20-year time horizon Markov model of HCV liver disease progression was developed. […]

Book Review: Overcharged

from Healthcare Economist at http://bit.ly/2OfkqC8 on October 30, 2018 at 04:11AM In the book Overcharged, authors Charles Silver and David Hyman identify a number of problems with the current health care system.  Third party payment under a fee-for-service system means that providers have an incentive to provide more rather than less care.  Further, because the […]

ISPOR to Host Webinar Nov. 27

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2CQUTNT on October 30, 2018 at 12:01AM The International Society for Pharmacoeconomics and Outcomes Research is set to host a Nov. 27 webinar titled “Mapping to Estimate Health-State Utility from Non-Preference-Based Outcomes Measures.” To register, click here.

UnitedHealth’s Genoa Acquisition Boosts OptumRx’s Position

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2P1EQnt on October 30, 2018 at 12:01AM UnitedHealth Group’s acquisition of Genoa HealthCare bolsters OptumRx’s competitive position in the pharmacy benefit arena, according to an MMIT report. KPMG’s Ashram Shehata says the purchase strengthen’s UnitedHealth amid huge shifts in the industry, including the CVS-Aetna and Cigna-Express Scripts deals. […]

Genes, Education, and Labor Market Outcomes: Evidence from the Health and Retirement Study

from Health Economics at http://bit.ly/2PtmWtg on October 30, 2018 at 12:21AM Recent advances have led to the discovery of specific genetic variants that predict educational attainment. We study how these variants, summarized as a linear index — known as a polygenic score — are associated with human capital accumulation and labor market outcomes in the […]

PhRMA’s Ubl: Trump Drug Pricing Plan Imports ‘Foreign Price Controls’

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2Q5hOZs on October 29, 2018 at 11:31PM PhRMA CEO Stephen Ubl slammed the Trump administration’s latest proposal to combat high drug prices, calling it the importation of “foreign price controls,” PMLiVE reports. The plan, which was unveiled last week, would look to bring the price of drugs covered […]